Your browser doesn't support javascript.
[Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules].
Yan, Bo-Hua; Jiang, Zhi-Wei; Zeng, Jie-Ping; Tang, Jian-Yuan; Ding, Hong; Xia, Jie-Lai; Qin, Shao-Rong; Jin, Si-Cen; Lu, Yun; Zhang, Na; Wang, Zhi-Hong; Li, Hai-Yan; Sang, Xiao-Ya; Wu, Li-Na; Tang, Shi-Yun; Li, Yan; Tao, Meng-Yao; Wang, Qiao-Ling; Wang, Jun-Dong; Xie, Hong-Yan; Chen, Qi-Yuan; Yang, Sheng-Wen; Hu, Nian-Shuang; Yang, Jian-Qiong; Bao, Xiao-Xia; Zhang, Qiong; Yang, Xiao-Li; Jiang, Chang-Yong; Luo, Hong-Yan; Cai, Zheng-Hua; Yu, Shu-Guang.
  • Yan BH; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Jiang ZW; Beijing Key Tech Statistical Consulting Co., Ltd. Beijing 100015, China.
  • Zeng JP; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Tang JY; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Ding H; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Xia JL; Air Force Military Medical University of People's Liberation Army Xi'an 710032, China.
  • Qin SR; Taiji Group Co., Ltd. Chongqing 408000, China.
  • Jin SC; Taiji Group Co., Ltd. Chongqing 408000, China.
  • Lu Y; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Zhang N; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Wang ZH; Chengdu Zhongxiang Pharmaceutical Technology Co., Ltd. Chengdu 610000, China.
  • Li HY; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Sang XY; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Wu LN; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Tang SY; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Li Y; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Tao MY; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Wang QL; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Wang JD; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Xie HY; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China.
  • Chen QY; Yingmenkou Community Service Center Chengdu 610036, China.
  • Yang SW; Xi'anlu Community Service Center Chengdu 610072, China.
  • Hu NS; Jiangxijie Community Service Center Chengdu 610041, China.
  • Yang JQ; Supo Community Service Center Chengdu 610091, China.
  • Bao XX; Caoshi Yuhe Community Service Center Chengdu 610014, China.
  • Zhang Q; Shuangnan Community Service Center Chengdu 610047, China.
  • Yang XL; Yulin Community Service Center Chengdu 610044, China.
  • Jiang CY; Jinyang Community Service Center Chengdu 610045, China.
  • Luo HY; Caotang Community Service Center Chengdu 610072, China.
  • Cai ZH; Xinhua Shaocheng Community Service Center Chengdu 610014, China.
  • Yu SG; Chengdu University of Traditional Chinese Medicine Chengdu 611137, China.
Zhongguo Zhong Yao Za Zhi ; 45(13): 2993-3000, 2020 Jul.
Article in Chinese | MEDLINE | ID: covidwho-679286
ABSTRACT
To scientifically evaluate the intervention effect of Chinese medicine preventive administration(combined use of Huo-xiang Zhengqi Oral Liquid and Jinhao Jiere Granules) on community population in the case of coronavirus disease 2019(COVID-19), a large cohort, prospective, randomized, and parallel-controlled clinical study was conducted. Total 22 065 subjects were included and randomly divided into 2 groups. The non-intervention group was given health guidance only, while the traditional Chinese medicine(TCM) intervention group was given two coordinated TCM in addition to health guidance. The medical instructions were as follows. Huoxiang Zhengqi Oral Liquid oral before meals, 10 mL/time, 2 times/day, a course of 5 days. Jinhao Jiere Granules dissolve in boiling water and take after meals, 8 g/time, 2 times/day, a course of 5 days, followed up for 14 days, respectively. The study found that with the intake of medication, the incidence rate of TCM intervention group was basically maintained at a low and continuous stable level(0.01%-0.02%), while the non-intervention group showed an overall trend of continuous growth(0.02%-0.18%) from 3 to 14 days. No suspected or confirmed COVID-19 case occurred in either group. There were 2 cases of colds in the TCM intervention group and 26 cases in the non-intervention group. The incidence of colds in the TCM intervention group was significantly lower(P<0.05) than that in the non-intervention group. In the population of 16-60 years old, the incidence rate of non-intervention and intervention groups were 0.01% and 0.25%, respectively. The difference of colds incidence between the two groups was statistically significant(P<0.05). In the population older than 60 years old, they were 0.04% and 0.21%, respectively. The incidence of colds in the non-intervention group was higher than that in the intervention group, but not reaching statistical difference. The protection rate of TCM for the whole population was 91.8%, especially for the population of age 16-60(95.0%). It was suggested that TCM intervention(combined use of Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules) could effectively protect community residents against respiratory diseases, such as colds, which was worthy of promotion in the community. In addition, in terms of safety, the incidence of adverse events and adverse reactions in the TCM intervention group was relatively low, which was basically consistent with the drug instructions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Drugs, Chinese Herbal / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Traditional medicine Limits: Adolescent / Adult / Humans / Middle aged / Young adult Language: Chinese Journal: Zhongguo Zhong Yao Za Zhi Journal subject: Pharmacology / Complementary Therapies Year: 2020 Document Type: Article Affiliation country: J.cnki.cjcmm.20200430.501

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Drugs, Chinese Herbal / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Traditional medicine Limits: Adolescent / Adult / Humans / Middle aged / Young adult Language: Chinese Journal: Zhongguo Zhong Yao Za Zhi Journal subject: Pharmacology / Complementary Therapies Year: 2020 Document Type: Article Affiliation country: J.cnki.cjcmm.20200430.501